AB0658 TWO-YEAR PERSISTENCE OF FIRST-LINE BIOLOGICAL OR JAK INHIBITOR TREATMENT IN PATIENTS WITH LONG-STANDING RHEUMATOID ARTHRITIS AND FAILURE TO TRIPLE THERAPY WITH SYNTHETIC DMARDs

Journal
Annals of the Rheumatic Diseases
ISSN
0003-4967
Date Issued
2024-06
Author(s)
D. García
M.P. Poblete
F. Valenzuela
M. Canals
C. Jaque
M. Armstrong
O. Valenzuela
Type
journal-article
DOI
URL
Cite this document
Ibáñez, S., García, D., Poblete, M. P., Valenzuela, F., Canals, M., Jaque, C., Armstrong, M., & Valenzuela, O. (2024). Ab0658 two-year persistence of first-line biological or jak inhibitor treatment in patients with long-standing rheumatoid arthritis and failure to triple therapy with synthetic dmards. Annals of the Rheumatic Diseases, 83, 1615. https://doi.org/10.1136/annrheumdis-2024-eular.252